Raed Labib
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Raed Labib has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Anis Irmawati
Department of Basic Dental Science and Public Health, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
4 shared publications - Fiki Muhammad Ridho
Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia, Indonesia
4 shared publications - Ridwan Alfatah
Faculty of Medicine, Universitas Islam Negeri Walisongo, Semarang, Indonesia, Indonesia
3 shared publications - Agus Aan Adriansyah
Universitas Nahdlatul Ulama Surabaya
1 shared publication Anisa Dias Nuraini
1 shared publicationAthallah Reyhan Darmawan
Universitas Airlangga, Indonesia
1 shared publication
Latest Publications
- Open Access
- 10 July 2026
- Published by Universidad Cientifica del Sur in Revista Científica Odontológica
- Vol. 14 (3) , e303
EFFICACY OF OMEGA-3 FATTY ACIDS SUPPLEMENTATION AS AN ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PERIODONTITIS: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Introduction: This study aimed to evaluate the efficacy of omega-3 fatty acids (n3-FA) supplementation as adjunct to scaling and root planing (SRP) in patients with periodontitis. Methods: A systematic review of randomized controlled trials (RCTs) evaluating n3-FA supplementation as a single adjunct therapy for SRP was conducted through a comprehensive search in Scopus, PubMed, Web of Science, Cochrane Library, and EBSCO. The Cochrane RoB2 tool was used as a tool for evaluating risk of bias. The outcomes of probing pocket depth (PPD) and clinical attachment level (CAL) were analyzed using a random-effects model metaanalysis and reported as mean differences (MD) and 95% confidence intervals (CI). The certainty of evidence was evaluated using the GRADE approach. RevMan 5.4 software was used for all statistical analysis. Results: Nine RCTs were included in the meta-analysis. Compared with SRP alone, adjunctive n3-FA supplementation showed a greater reduction in PPD (MD = -0.66; 95% CI: -1.03, -0.30; p = 0.0003; I2 = 91%) and gain in CAL (MD = -0.69; 95% CI: -1.06, -0.32; p =0.0002; I2 = 88%). Sensitivity and subgroup analyses yielded consistent effect directions, although the overall certainty of evidence was rated as low. Conclusion: Adjunctive n3-FA supplementation as a host modulation therapy may provide additional benefits when combined with SRP in patients with periodontitis. However, given the substantial heterogeneity and low level of evidence, these findings should be interpreted cautiously. Further high-quality, more rigorously designed RCTs are required to confirm their long-term efficacy and safety.
- 10 July 2026
- Published by Universidad Cientifica del Sur in Revista Científica Odontológica
- Vol. 14 (3) , e303
Open AccessEFFICACY OF OMEGA-3 FATTY ACIDS SUPPLEMENTATION AS AN ADJUNCT TO NONSURGICAL PERIODONTAL THERAPY IN PERIODONTITIS: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Introduction: This study aimed to evaluate the efficacy of omega-3 fatty acids (n3-FA) supplementation as adjunct to scaling and root planing (SRP) in patients with periodontitis. Methods: A systematic review of randomized controlled trials (RCTs) evaluating n3-FA supplementation as a single adjunct therapy for SRP was conducted through a comprehensive search in Scopus, PubMed, Web of Science, Cochrane Library, and EBSCO. The Cochrane RoB2 tool was used as a tool for evaluating risk of bias. The outcomes of probing pocket depth (PPD) and clinical attachment level (CAL) were analyzed using a random-effects model metaanalysis and reported as mean differences (MD) and 95% confidence intervals (CI). The certainty of evidence was evaluated using the GRADE approach. RevMan 5.4 software was used for all statistical analysis. Results: Nine RCTs were included in the meta-analysis. Compared with SRP alone, adjunctive n3-FA supplementation showed a greater reduction in PPD (MD = -0.66; 95% CI: -1.03, -0.30; p = 0.0003; I2 = 91%) and gain in CAL (MD = -0.69; 95% CI: -1.06, -0.32; p =0.0002; I2 = 88%). Sensitivity and subgroup analyses yielded consistent effect directions, although the overall certainty of evidence was rated as low. Conclusion: Adjunctive n3-FA supplementation as a host modulation therapy may provide additional benefits when combined with SRP in patients with periodontitis. However, given the substantial heterogeneity and low level of evidence, these findings should be interpreted cautiously. Further high-quality, more rigorously designed RCTs are required to confirm their long-term efficacy and safety.
- 24 June 2026
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 43, 42
Therapeutic efficacy of mesenchymal stem cells in periodontal regeneration: a systematic review and meta-analysis of clinical trials
Background: Periodontitis is a major global health problem that leads to destruction and loss of periodontal tissues. As conventional therapy has a limited capacity to restore the complex architecture of the periodontium, regenerative approaches have been explored. This meta-analysis evaluates the therapeutic efficacy of mesenchymal stem cells (MSCs) for periodontal regeneration in patients with periodontal defects.Methods: PubMed, Scopus, Web of Science, Dentistry & Oral Sciences Source, and the Cochrane Library were searched for clinical trials. The risk of bias was assessed using Cochrane RoB2. Random- or fixed-effects meta-analyses were used in the pooled analysis and reported as mean differences (MDs) and 95% confidence intervals (CIs). Certainty of evidence was rated using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE).Results: Ten clinical trials were included in the analysis. MSCs significantly improved probing pocket depth (MD, –0.51; 95% CI, –0.84 to –0.19; p<0.01; I2=62%), clinical attachment level (MD, –0.75; 95% CI, –0.95 to –0.54; p<0.01; I2=40%), cementoenamel junction to the base of defect (MD, –0.49; 95% CI, –0.95 to –0.02; p=0.04; I2=63%), and intrabony defect (MD, –1.09; 95% CI, –1.60 to –0.57; p<0.01; I2=71%). However, no significant improvement in gingival recession was observed (MD, –0.18; 95% CI, –0.38 to 0.01; p=0.07; I2=0%). The GRADE assessment indicated a high-to-moderate certainty.Conclusion: MSCs represent a promising strategy for periodontal regeneration. Nevertheless, the limited number of studies and the observed heterogeneity warrant cautious interpretation. Larger methodologically rigorous trials are needed to clarify the true contribution of MSCs to periodontal regeneration.
- 24 June 2026
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 43, 42
Therapeutic efficacy of mesenchymal stem cells in periodontal regeneration: a systematic review and meta-analysis of clinical trials
Background: Periodontitis is a major global health problem that leads to destruction and loss of periodontal tissues. As conventional therapy has a limited capacity to restore the complex architecture of the periodontium, regenerative approaches have been explored. This meta-analysis evaluates the therapeutic efficacy of mesenchymal stem cells (MSCs) for periodontal regeneration in patients with periodontal defects.Methods: PubMed, Scopus, Web of Science, Dentistry & Oral Sciences Source, and the Cochrane Library were searched for clinical trials. The risk of bias was assessed using Cochrane RoB2. Random- or fixed-effects meta-analyses were used in the pooled analysis and reported as mean differences (MDs) and 95% confidence intervals (CIs). Certainty of evidence was rated using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE).Results: Ten clinical trials were included in the analysis. MSCs significantly improved probing pocket depth (MD, –0.51; 95% CI, –0.84 to –0.19; p<0.01; I2=62%), clinical attachment level (MD, –0.75; 95% CI, –0.95 to –0.54; p<0.01; I2=40%), cementoenamel junction to the base of defect (MD, –0.49; 95% CI, –0.95 to –0.02; p=0.04; I2=63%), and intrabony defect (MD, –1.09; 95% CI, –1.60 to –0.57; p<0.01; I2=71%). However, no significant improvement in gingival recession was observed (MD, –0.18; 95% CI, –0.38 to 0.01; p=0.07; I2=0%). The GRADE assessment indicated a high-to-moderate certainty.Conclusion: MSCs represent a promising strategy for periodontal regeneration. Nevertheless, the limited number of studies and the observed heterogeneity warrant cautious interpretation. Larger methodologically rigorous trials are needed to clarify the true contribution of MSCs to periodontal regeneration.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Journal of Applied Oral Science
- Vol. 34
Potency of moderate-intensity exercise on caspase-8 and caspase-9 expression in a DMBA-induced oral epithelial dysplasia rat model
Background Oral squamous cell carcinoma (OSCC) accounts for approximately 90% of oral cancers, with tobacco exposure representing one of its major risk factors. The tobacco carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) induces oral epithelial dysplasia, a premalignant lesion. Caspase-8 and caspase-9 are initiator caspases that trigger apoptosis in dysplastic cells. Currently, disease management focuses on prevention. Moderate-intensity exercise has been reported to modulate apoptosis-related signaling and may contribute to cancer prevention. Objective To evaluate the potency of moderate-intensity exercise on caspase-8 and -9 expression in a DMBA-induced oral dysplasia rat model. Methodology A total of 24 Wistar rats were randomly divided into four groups: K1 (no exercise, no DMBA), K2 (exercise, no DMBA), K3 (no exercise, DMBA), K4 (exercise, DMBA). Exercise consisted of moderate-intensity swimming at 70% MWC, performed 3x/week for 6 weeks. DMBA (0.02 mg/kg body weight) was injected into the buccal mucosa of the canine region twice weekly for 2 weeks. At the 7th week, the rats were anesthetized with ketamine (10 mg/kg body weight), euthanized by cervical dislocation, and buccal tissue specimens were collected. Immunohistochemical staining was performed to obtain caspase-8 and -9 expression. Data were analyzed in SPSS version 29.0. Results All groups presented significant differences in caspase-8 (p = 0.004) and caspase-9 (p <0.001) expression. Caspase-8 and caspase-9 expression was significantly higher in K4 than in K3, with expression restored to levels comparable to the untreated control group (K1). Conclusion Moderate-intensity exercise restored caspase-8 and caspase-9 expression suppressed by DMBA exposure, suggesting preservation of apoptotic signaling in DMBA-induced Wistar rats.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Journal of Applied Oral Science
- Vol. 34
Open AccessPotency of moderate-intensity exercise on caspase-8 and caspase-9 expression in a DMBA-induced oral epithelial dysplasia rat model
Background Oral squamous cell carcinoma (OSCC) accounts for approximately 90% of oral cancers, with tobacco exposure representing one of its major risk factors. The tobacco carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) induces oral epithelial dysplasia, a premalignant lesion. Caspase-8 and caspase-9 are initiator caspases that trigger apoptosis in dysplastic cells. Currently, disease management focuses on prevention. Moderate-intensity exercise has been reported to modulate apoptosis-related signaling and may contribute to cancer prevention. Objective To evaluate the potency of moderate-intensity exercise on caspase-8 and -9 expression in a DMBA-induced oral dysplasia rat model. Methodology A total of 24 Wistar rats were randomly divided into four groups: K1 (no exercise, no DMBA), K2 (exercise, no DMBA), K3 (no exercise, DMBA), K4 (exercise, DMBA). Exercise consisted of moderate-intensity swimming at 70% MWC, performed 3x/week for 6 weeks. DMBA (0.02 mg/kg body weight) was injected into the buccal mucosa of the canine region twice weekly for 2 weeks. At the 7th week, the rats were anesthetized with ketamine (10 mg/kg body weight), euthanized by cervical dislocation, and buccal tissue specimens were collected. Immunohistochemical staining was performed to obtain caspase-8 and -9 expression. Data were analyzed in SPSS version 29.0. Results All groups presented significant differences in caspase-8 (p = 0.004) and caspase-9 (p <0.001) expression. Caspase-8 and caspase-9 expression was significantly higher in K4 than in K3, with expression restored to levels comparable to the untreated control group (K1). Conclusion Moderate-intensity exercise restored caspase-8 and caspase-9 expression suppressed by DMBA exposure, suggesting preservation of apoptotic signaling in DMBA-induced Wistar rats.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Dental Journal
- Vol. 36, e25-6808
SHED-Secretome Gel Promotes Early Alveolar Bone Healing via Osteoblast-Osteoclast Modulation
Post-extraction alveolar bone healing is crucial for dental rehabilitation, depending on the balance between osteoblast and osteoclast activity. This study evaluated the potential of SHED (stem cells from human exfoliated deciduous teeth)-derived secretome gel in promoting bone regeneration. Eighteen male Rattus norvegicus were divided into three groups: negative control (placebo gel), positive control (absorbable gelatin sponge), and treatment (SHED-secretome gel). Maxillary first molars were extracted, and the respective materials were applied to the sockets. On day 7, histological samples were analyzed. Results showed that the SHED-secretome group exhibited significantly higher osteoblast and osteoclast numbers compared to controls, indicating active and balanced bone remodeling. The bone matrix appeared more organized, suggesting accelerated early healing. Statistical analysis (Kruskal-Wallis and Mann-Whitney U with Bonferroni correction) confirmed significant differences (p < 0.01) in osteoblast and osteoclast counts across groups. In conclusion, SHED-secretome gel enhances early alveolar bone healing by promoting coordinated osteoblast-osteoclast activity essential for physiological bone remodeling.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Dental Journal
- Vol. 36, e25-6808
Open AccessSHED-Secretome Gel Promotes Early Alveolar Bone Healing via Osteoblast-Osteoclast Modulation
Post-extraction alveolar bone healing is crucial for dental rehabilitation, depending on the balance between osteoblast and osteoclast activity. This study evaluated the potential of SHED (stem cells from human exfoliated deciduous teeth)-derived secretome gel in promoting bone regeneration. Eighteen male Rattus norvegicus were divided into three groups: negative control (placebo gel), positive control (absorbable gelatin sponge), and treatment (SHED-secretome gel). Maxillary first molars were extracted, and the respective materials were applied to the sockets. On day 7, histological samples were analyzed. Results showed that the SHED-secretome group exhibited significantly higher osteoblast and osteoclast numbers compared to controls, indicating active and balanced bone remodeling. The bone matrix appeared more organized, suggesting accelerated early healing. Statistical analysis (Kruskal-Wallis and Mann-Whitney U with Bonferroni correction) confirmed significant differences (p < 0.01) in osteoblast and osteoclast counts across groups. In conclusion, SHED-secretome gel enhances early alveolar bone healing by promoting coordinated osteoblast-osteoclast activity essential for physiological bone remodeling.